Search - tctmd.com

Displaying 381 - 400 of 6712

Sort: Relevancy | Date

Presentation NY Valves 2025

Prognostic Value of Baseline Aortic Valve Gradient in Acute Heart Failure Patients Undergoing TAVR

Presenter: Nirat Beohar

June 26, 2025

Presentation NY Valves 2025

Novel Balloon-Expandable Transcatheter Heart Valve for Aortic Stenosis: Insights from the First-In-Human Series (Abbott)

Presenter: Susheel K. Kodali

June 26, 2025

Presentation NY Valves 2025

Management of Valve Balloon Rupture: a Case-Based Tutorial

Presenter: Itsik Ben-Dor

June 26, 2025

Presentation NY Valves 2025

Fluoroscopic Evaluation of Sapien 3 Movement in Short-in-Tall Redo-TAVR: A First-in-Human Analysis

Presenter: Takayuki Onishi

June 26, 2025

Presentation NY Valves 2025

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Presenter: Chloe Kharsa

June 26, 2025

Presentation NY Valves 2025

Percutaneous or Surgical Trans-Axillary Access for TAVR With Hostile Femoral Access: Insights From the HOSTILE Registry

Presenter: Matteo Sturla

June 26, 2025

Presentation NY Valves 2025

Balloon Assisted Shortening of TAVR Valve: Reducing Risk of Coronary Obstruction

Presenter: Yasemin Ciftcikal

June 26, 2025

Presentation NY Valves 2025

Optimizing Outflow During Redo-TAVR With a 23 mm Sapien UR for a Degenerated Evolut PRO 26 mm Valve

Presenter: Srivatsan Swaminathan

June 26, 2025

Presentation NY Valves 2025

Keynote: The Case for Tandem or Staged AF Ablation and LAAC: Beyond OPTION

Presenter: Rodney Horton

June 26, 2025

Presentation NY Valves 2025

Surgical vs. Medical Treatment of Post-TAVR Endocarditis: A Meta-Analysis of Outcomes and Insights From Contemporary Cohorts

Presenter: Dimitrios Magouliotis

June 26, 2025

Presentation NY Valves 2025

LAAC After TAVR: Key Lessons From WATCH TAVR

Presenter: Samir R. Kapadia

June 26, 2025

Presentation NY Valves 2025

Presentation 3: Siegel TAVR

Presenter: Pradeep K. Yadav

June 26, 2025

Presentation NY Valves 2025

Presentation 2: DurAVR

Presenter: Ole De Backer

June 26, 2025

Presentation NY Valves 2025

Presentation 1: Encantor TAVR

Presenter: Susheel K. Kodali

June 26, 2025

Presentation NY Valves 2025

Treatment of Childhood Cancer Survivor With Severe Aortic and Mitral Insufficiency Using TAVR and TMVR

Presenter: Jadon Ray Rajagopal

June 26, 2025

Presentation NY Valves 2025

SAVR With Y-Incision Aortic Annular Enlargement Outperforms TAVR in Hemodynamics in Women With Native Aortic Stenosis

Presenter: Bo Yang

June 26, 2025

Presentation NY Valves 2025

Feasibility of Valve-in-Valve After TAVR: A Comparative Study of Sapien 3 vs. Surgical AVR

Presenter: Tej Sheth

June 26, 2025

Presentation NY Valves 2025

An Algorithm for Managing Catastrophic Hypotension During TAVR

Presenter: James M. McCabe

June 26, 2025

Presentation NY Valves 2025

Valve Embolization: Treatment Strategies

Presenter: Stanley J. Chetcuti

June 26, 2025

Presentation NY Valves 2025

Late Clinical Outcomes After TAVR: Impact of Frailty and Social Vulnerability in a “Real World” Administrative Claims Database

Presenter: Gregory P. Fontana

June 26, 2025

Advertisement

Prognostic Value of Baseline Aortic Valve Gradient in Acute Heart Failure Patients Undergoing TAVR

Novel Balloon-Expandable Transcatheter Heart Valve for Aortic Stenosis: Insights from the First-In-Human Series (Abbott)

Management of Valve Balloon Rupture: a Case-Based Tutorial

Fluoroscopic Evaluation of Sapien 3 Movement in Short-in-Tall Redo-TAVR: A First-in-Human Analysis

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Percutaneous or Surgical Trans-Axillary Access for TAVR With Hostile Femoral Access: Insights From the HOSTILE Registry

Balloon Assisted Shortening of TAVR Valve: Reducing Risk of Coronary Obstruction

Optimizing Outflow During Redo-TAVR With a 23 mm Sapien UR for a Degenerated Evolut PRO 26 mm Valve

Keynote: The Case for Tandem or Staged AF Ablation and LAAC: Beyond OPTION

Surgical vs. Medical Treatment of Post-TAVR Endocarditis: A Meta-Analysis of Outcomes and Insights From Contemporary Cohorts

LAAC After TAVR: Key Lessons From WATCH TAVR

Presentation 3: Siegel TAVR

Presentation 2: DurAVR

Presentation 1: Encantor TAVR

Treatment of Childhood Cancer Survivor With Severe Aortic and Mitral Insufficiency Using TAVR and TMVR

SAVR With Y-Incision Aortic Annular Enlargement Outperforms TAVR in Hemodynamics in Women With Native Aortic Stenosis

Feasibility of Valve-in-Valve After TAVR: A Comparative Study of Sapien 3 vs. Surgical AVR

An Algorithm for Managing Catastrophic Hypotension During TAVR

Valve Embolization: Treatment Strategies

Late Clinical Outcomes After TAVR: Impact of Frailty and Social Vulnerability in a “Real World” Administrative Claims Database

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content